4//SEC Filing
MARTIN WILLIAM E. III 4
Accession 0000899243-22-033827
CIK 0001823239other
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 4:39 PM ET
Size
12.9 KB
Accession
0000899243-22-033827
Insider Transaction Report
Form 4
MARTIN WILLIAM E. III
Chief Executive Officer
Transactions
- Award
Class A Common Stock
2022-10-17+120,019→ 120,019 total - Award
Class A Common Stock
2022-10-17+228,036→ 348,055 total - Award
Employee Stock Option (Right to Buy)
2022-10-17+403,946→ 403,946 totalExercise: $19.42Exp: 2032-10-17→ Class A Common Stock (403,946 underlying) - Award
Performance Stock Units
2022-10-17+240,038→ 240,038 totalExp: 2025-10-17→ Class A Common Stock (240,038 underlying)
Footnotes (4)
- [F1]Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan (the "Omnibus Incentive Plan"). Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest 50% on each of October 17, 2023 and October 17, 2024, subject to the Reporting Person's continued employment with the Issuer.
- [F2]Represents RSUs awarded under the Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of October 17, 2023, October 17, 2024, and October 17, 2025, subject to the Reporting Person's continued employment with the Issuer.
- [F3]Represents options awarded under the Omnibus Incentive Plan. These options will vest 25% on October 17, 2023 and in near-equal 1/36th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer.
- [F4]Represents performance stock units ("PSUs") awarded under the Omnibus Incentive Plan. Each PSU represents the contingent right to receive one share of Class A Common Stock of the Issuer. The PSUs will vest on October 17, 2025, if and to the extent the 60-trading day volume-weighted average stock price of the Class A Common Stock of the Issuer equals or exceeds certain thresholds, provided that in the event of a Change in Control (as defined in the Omnibus Incentive Plan) prior to October 17, 2025, the PSUs will convert to time-based RSUs that will fully vest on October 17, 2025, subject to the Reporting Person's continued employment with the Issuer.
Documents
Issuer
MARAVAI LIFESCIENCES HOLDINGS, INC.
CIK 0001823239
Entity typeother
Related Parties
1- filerCIK 0001949513
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 4:39 PM ET
- Size
- 12.9 KB